Semaglutide Injection 6.8mg/3ml PFS Manufacturer
Our Certifications
WHO-GMPCertified
GMPCertified
ISO 9001:2015Certified
GLPCertified
WHO-GMPCertified
GMPCertified
ISO 9001:2015Certified
GLPCertified
Global Presence
Our products are trusted and supplied across 40+ countries worldwide.
India
USA
UK
Canada
Germany
Australia
UAE
Brazil
South Africa
Malaysia
India
USA
UK
Canada
Germany
Australia
UAE
Brazil
South Africa
Malaysia
Product Overview
Sanjar Pharma manufactures Semaglutide Injection 6.8mg/3ml in a prefilled syringe format at its WHO-GMP compliant sterile injectable manufacturing facility. The product is manufactured using validated pharmaceutical processes, controlled cleanroom environments, and advanced quality management systems designed to support product consistency and regulatory compliance.
Semaglutide is a GLP-1 Receptor Agonist that forms part of a high-growth specialty injectable pharmaceutical segment. The prefilled syringe presentation provides a ready-to-administer dosage format that supports administration efficiency, dosing precision, and streamlined handling within healthcare environments.
Manufactured under strict sterile conditions and supported by comprehensive analytical testing, microbiological monitoring, and quality assurance programs, Sanjar Pharma supplies Semaglutide Injection to pharmaceutical companies, healthcare providers, distributors, procurement organizations, and international pharmaceutical markets.
Technical Specifications
| Generic Name | Semaglutide |
|---|---|
| Strength | 6.8mg/3ml |
| Brand Name | SP-TIDE |
| Therapeutic Category | Antidiabetic Agent |
| Dosage Form | Prefilled Syringe (PFS) |
| Route of Administration | Subcutaneous Injection |
| Product Type | Sterile Injectable |
| Manufacturing Standard | WHO-GMP |
| Supply Type | Commercial Supply |
| Contract Manufacturing | Available |
| Third Party Manufacturing | Available |
| Regulatory Documentation | Available Upon Request |
| Storage Condition | As Per Approved Product Specifications |
| Export Supply | Available |
WHO-GMP Specialty Injectable Manufacturing
Sanjar Pharma operates a WHO-GMP compliant sterile injectable manufacturing facility equipped with advanced production technologies, analytical laboratories, microbiology testing infrastructure, and validated utilities designed to support specialty pharmaceutical manufacturing and global supply requirements.
Why Choose Sanjar Pharma for Semaglutide Injection Manufacturing
-
Expertise in Sterile Injectable Manufacturing
-
WHO-GMP Certified Pharmaceutical Manufacturing Facility
-
Advanced Analytical Testing Capabilities
-
Comprehensive Quality Assurance Systems
-
Specialty Pharmaceutical Manufacturing Expertise
-
Export-Oriented Pharmaceutical Operations
-
Contract Manufacturing Support
-
Third Party Manufacturing Solutions
Industries We Serve
Enquire About This Product
Submit your requirement parameters below for rapid commercial export handling.
